Literature DB >> 22238189

General and disease-specific psychosocial adjustment in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy with implantable cardioverter defibrillators: a large cohort study.

Cynthia A James1, Crystal Tichnell, Brittney Murray, Amy Daly, Samuel F Sears, Hugh Calkins.   

Abstract

BACKGROUND: Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is characterized by frequent life-threatening ventricular arrhythmias, diagnosed on average in the teens to mid-50s and commonly treated by implantable cardioverter defibrillators (ICDs). As younger age and high frequency of ICD discharges are risk factors for difficulties in psychosocial adjustment, we developed a study to assess psychosocial adjustment among patients with ARVD/C and to determine risk factors for poor adjustment in this high-risk population. METHODS AND
RESULTS: Eighty-six adults enrolled in the Johns Hopkins ARVD Registry (38 male; mean age, 45.4±12.9 years), with an ICD in place for a median 3.2 years (range, 0.2 to 20.1 years), completed a set of questionnaires measuring ICD-specific anxiety (Florida Shock Anxiety Scale), device acceptance (Florida Patient Acceptance Survey), anxiety and depression (Hospital Anxiety and Depression Scale), and functional capacity (Duke Activity Status Index). Although overall device acceptance (Florida Patient Acceptance Survey mean, 76.7±15.3) was normative, patients with ARVD/C had substantially elevated body image concerns (Florida Patient Acceptance Survey subscale mean, 17.9±23.5) and device-related distress (subscale mean, 26.5±19.2), particularly among younger patients (P<0.01). Patients with ARVD/C had elevated ICD-specific (Florida Shock Anxiety Scale mean, 22.9±7.8) and general clinical anxiety (Hospital Anxiety and Depression Scale anxiety subscale mean, 6.2±3.9). Device-specific anxiety (Florida Shock Anxiety Scale) was predicted by younger age (P<0.0001), poorer functional capacity (P=0.016), having an ICD shock (P=0.003), and shorter time since ICD implant (P=0.007). Participants with poor device adjustment had an increased likelihood of clinically significant anxiety (P=0.006) and depression (P=0.008).
CONCLUSIONS: Patients with ARVD/C are at elevated risk for anxiety, and young patients face challenges with device acceptance. Risk factors for poor device adjustment may be used clinically to identify patients at high-risk of psychological distress.

Entities:  

Mesh:

Year:  2012        PMID: 22238189     DOI: 10.1161/CIRCGENETICS.111.960898

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN: 1942-3268


  19 in total

Review 1.  Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): a review of molecular and clinical literature.

Authors:  Brittney Murray
Journal:  J Genet Couns       Date:  2012-03-17       Impact factor: 2.537

2.  Risk of Cardiac Events Associated With Antidepressant Therapy in Patients With Long QT Syndrome.

Authors:  Meng Wang; Barbara Szepietowska; Bronislava Polonsky; Scott McNitt; Arthur J Moss; Wojciech Zareba; David S Auerbach
Journal:  Am J Cardiol       Date:  2017-11-13       Impact factor: 2.778

3.  Psychosocial Implications of Living with Catecholaminergic Polymorphic Ventricular Tachycardia in Adulthood.

Authors:  Ebony Richardson; Catherine Spinks; Andrew Davis; Christian Turner; John Atherton; Julie McGaughran; Christopher Semsarian; Jodie Ingles
Journal:  J Genet Couns       Date:  2017-09-23       Impact factor: 2.537

4.  Psychosocial Impact of a Positive Gene Result for Asymptomatic Relatives at Risk of Hypertrophic Cardiomyopathy.

Authors:  Carissa Bonner; Catherine Spinks; Christopher Semsarian; Alex Barratt; Jodie Ingles; Kirsten McCaffery
Journal:  J Genet Couns       Date:  2018-02-22       Impact factor: 2.537

5.  Sports in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy and desmosomal mutations.

Authors:  A C Sawant; H Calkins
Journal:  Herz       Date:  2015-05       Impact factor: 1.443

6.  Minding the Genes: a Multidisciplinary Approach towards Genetic Assessment of Cardiovascular Disease.

Authors:  Ashley Rhodes; Lindsey Rosman; John Cahill; Jodie Ingles; Brittney Murray; Crystal Tichnell; Cynthia A James; Samuel F Sears
Journal:  J Genet Couns       Date:  2016-09-30       Impact factor: 2.537

7.  Yield of serial evaluation in at-risk family members of patients with ARVD/C.

Authors:  Anneline S J M te Riele; Cynthia A James; Neda Rastegar; Aditya Bhonsale; Brittney Murray; Crystal Tichnell; Daniel P Judge; David A Bluemke; Stefan L Zimmerman; Ihab R Kamel; Hugh Calkins; Harikrishna Tandri
Journal:  J Am Coll Cardiol       Date:  2014-07-22       Impact factor: 24.094

8.  Update on Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C).

Authors:  Cynthia A James; Hugh Calkins
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-08

9.  Perceived economic burden associated with an inherited cardiac condition: a qualitative inquiry with families affected by arrhythmogenic right ventricular cardiomyopathy.

Authors:  Holly Etchegary; Glenn Enright; Rick Audas; Daryl Pullman; Terry-Lynn Young; Kathy Hodgkinson
Journal:  Genet Med       Date:  2015-10-29       Impact factor: 8.822

Review 10.  Psychological Issues in Managing Families with Inherited Cardiovascular Diseases.

Authors:  Jodie Ingles
Journal:  Cold Spring Harb Perspect Med       Date:  2020-09-01       Impact factor: 5.159

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.